Titre : Inhibiteurs de la libération d'acétylcholine

Inhibiteurs de la libération d'acétylcholine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Craniosynostoses
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de la libération d'acétylcholine : Questions médicales les plus fréquentes", "headline": "Inhibiteurs de la libération d'acétylcholine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteurs de la libération d'acétylcholine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-06", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteurs de la libération d'acétylcholine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Agents cholinergiques", "url": "https://questionsmedicales.fr/mesh/D018678", "about": { "@type": "MedicalCondition", "name": "Agents cholinergiques", "code": { "@type": "MedicalCode", "code": "D018678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.577.120" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la libération d'acétylcholine", "alternateName": "Acetylcholine Release Inhibitors", "code": { "@type": "MedicalCode", "code": "D065087", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ikunobu Muramatsu", "url": "https://questionsmedicales.fr/author/Ikunobu%20Muramatsu", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan." } }, { "@type": "Person", "name": "Junsuke Uwada", "url": "https://questionsmedicales.fr/author/Junsuke%20Uwada", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan." } }, { "@type": "Person", "name": "Kiyonao Sada", "url": "https://questionsmedicales.fr/author/Kiyonao%20Sada", "affiliation": { "@type": "Organization", "name": "Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan." } }, { "@type": "Person", "name": "Takayoshi Masuoka", "url": "https://questionsmedicales.fr/author/Takayoshi%20Masuoka", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan." } }, { "@type": "Person", "name": "Takashi Yazawa", "url": "https://questionsmedicales.fr/author/Takashi%20Yazawa", "affiliation": { "@type": "Organization", "name": "Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparative Analysis of 2D and 3D Metrics for Evaluation of Postoperative Outcomes Following Endoscopic Suturectomy for Sagittal Craniosynostosis.", "datePublished": "2023-07-21", "url": "https://questionsmedicales.fr/article/37477605", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SCS.0000000000009485" } }, { "@type": "ScholarlyArticle", "name": "Cosmetic satisfaction and patient-reported outcomes following surgical treatment of single-suture craniosynostosis: a systematic review.", "datePublished": "2023-07-21", "url": "https://questionsmedicales.fr/article/37477663", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00381-023-06063-3" } }, { "@type": "ScholarlyArticle", "name": "Multicenter comparison of head shape outcomes for three minimally invasive strip craniectomy techniques for sagittal craniosynostosis.", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37347639", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3171/2023.5.PEDS22528" } }, { "@type": "ScholarlyArticle", "name": "Use of Subcutaneous Injection of Epinephrine and Triamcinolone with Tranexamic Acid Reduces Blood Loss, Transfusion Rates, and Length of Stay in Open Sagittal Craniosynostosis Repair.", "datePublished": "2023-05-29", "url": "https://questionsmedicales.fr/article/37246301", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SCS.0000000000009443" } }, { "@type": "ScholarlyArticle", "name": "Dissecting calvarial bones and sutures at single-cell resolution.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37171117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/brv.12975" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Agents neuromédiateurs", "item": "https://questionsmedicales.fr/mesh/D018377" }, { "@type": "ListItem", "position": 6, "name": "Agents cholinergiques", "item": "https://questionsmedicales.fr/mesh/D018678" }, { "@type": "ListItem", "position": 7, "name": "Inhibiteurs de la libération d'acétylcholine", "item": "https://questionsmedicales.fr/mesh/D065087" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteurs de la libération d'acétylcholine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la libération d'acétylcholine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteurs de la libération d'acétylcholine", "description": "Comment diagnostiquer une inhibition de l'acétylcholine ?\nQuels tests sont utilisés pour évaluer l'acétylcholine ?\nQuels symptômes indiquent une inhibition d'acétylcholine ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on utiliser l'imagerie pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteurs de la libération d'acétylcholine", "description": "Quels sont les symptômes courants d'une inhibition ?\nL'inhibition affecte-t-elle la cognition ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes digestifs ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteurs de la libération d'acétylcholine", "description": "Peut-on prévenir l'inhibition d'acétylcholine ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique est-il bénéfique ?\nLe stress peut-il aggraver l'inhibition ?\nDes contrôles réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteurs de la libération d'acétylcholine", "description": "Quels traitements sont disponibles pour l'inhibition ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa rééducation est-elle recommandée ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteurs de la libération d'acétylcholine", "description": "Quelles complications peuvent survenir ?\nL'inhibition peut-elle entraîner des hospitalisations ?\nY a-t-il un risque de décès ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteurs de la libération d'acétylcholine", "description": "Quels sont les facteurs de risque d'inhibition ?\nL'âge est-il un facteur de risque ?\nLes médicaments peuvent-ils influencer le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections virales sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Craniosynostoses&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une inhibition de l'acétylcholine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests neurologiques et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'acétylcholine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests électromyographiques et des analyses sanguines peuvent être utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une inhibition d'acétylcholine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la faiblesse musculaire et la fatigue peuvent indiquer une inhibition." } }, { "@type": "Question", "name": "Les antécédents médicaux sont-ils importants ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents médicaux aident à identifier des causes potentielles d'inhibition." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie cérébrale peut aider à exclure d'autres pathologies neurologiques." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une inhibition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, fatigue, et troubles de la coordination." } }, { "@type": "Question", "name": "L'inhibition affecte-t-elle la cognition ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des troubles de la mémoire et de la concentration." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires peuvent survenir en cas d'inhibition sévère." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes digestifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées et des troubles gastro-intestinaux peuvent se manifester." } }, { "@type": "Question", "name": "Peut-on prévenir l'inhibition d'acétylcholine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée riche en antioxydants peut soutenir la santé neuronale." } }, { "@type": "Question", "name": "L'exercice physique est-il bénéfique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la fonction musculaire et nerveuse." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'inhibition ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les symptômes d'inhibition d'acétylcholine." } }, { "@type": "Question", "name": "Des contrôles réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers permettent de surveiller l'évolution et d'ajuster les traitements." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'inhibition ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anticholinestérasiques et des thérapies physiques." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent améliorer les symptômes et la qualité de vie des patients." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées et des crampes peuvent survenir." } }, { "@type": "Question", "name": "La rééducation est-elle recommandée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rééducation physique peut aider à renforcer les muscles et améliorer la fonction." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles respiratoires et des crises musculaires." } }, { "@type": "Question", "name": "L'inhibition peut-elle entraîner des hospitalisations ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cas graves peuvent nécessiter une hospitalisation pour surveillance." } }, { "@type": "Question", "name": "Y a-t-il un risque de décès ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Dans des cas extrêmes, l'inhibition sévère peut entraîner des risques mortels." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'inhibition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé est un facteur de risque pour les troubles de la libération d'acétylcholine." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent augmenter le risque d'inhibition d'acétylcholine." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections virales sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales peuvent déclencher des troubles de la libération d'acétylcholine." } } ] } ] }

Sources (211 au total)

Cosmetic satisfaction and patient-reported outcomes following surgical treatment of single-suture craniosynostosis: a systematic review.

This study provides a systematic review on cosmetic satisfaction and other patient-reported outcomes (PROMs) of patients who underwent surgical treatment of SSC.... A systematic review of all articles published from inception to 1 June 2022 was performed. Articles were included if they reported on subjective assessment of cosmetic satisfaction or other PROMs by p... Twelve articles, describing 724 surgical treatments of SSC, met the inclusion criteria. Cosmetic satisfaction was evaluated in the following ways: 1) use of the VAS score, binary questions or a 5-poin... This systematic review illuminates that there is a wide variation in outcomes for evaluating cosmetic satisfaction and other PROMs of patients who underwent surgical treatment of SSC, suggesting that ...

Multicenter comparison of head shape outcomes for three minimally invasive strip craniectomy techniques for sagittal craniosynostosis.

A literature gap exists comparing whole head shape outcome following correction of sagittal craniosynostosis. The objective of this multicenter study was to provide an analysis of long-term results fo... Pre- and postoperative 3D stereophotogrammetric images were collected from patients who underwent craniosynostosis surgery. Procedures were divided among institutions as follows: spring-assisted strip... Patients in the spring-assisted strip craniectomy group showed normalization of frontal bossing and skull height compared with age-matched controls, whereas patients undergoing wide-strip craniectomy ... This large, retrospective, multicenter study illustrated whole head shape outcomes from three different craniectomy procedures. Although each procedure showed some differences in loci of primary corre...

Use of Subcutaneous Injection of Epinephrine and Triamcinolone with Tranexamic Acid Reduces Blood Loss, Transfusion Rates, and Length of Stay in Open Sagittal Craniosynostosis Repair.

In 2017, we adopted the use of triamcinolone/epinephrine (TAC/Epi) scalp injection and later added tranexamic acid (TXA) in open sagittal synostosis surgery. We believe that this reduced blood loss an... A total of 107 consecutive patients operated for sagittal synostosis aged <4 months from 2007 to 2019 were retrospectively reviewed. We collected demographics [age, sex, weight at surgery, and length ... There were 3 groups: 1/4% bupivacaine/epinephrine (N=64), TAC/Epi (N=13), and TAC/Epi with TXA bolus/infusion intraoperatively (N=30). Groups receiving TAC/Epi or TAC/Epi with TXA had lower mean EBL (... Use of TAC/Epi alone reduced EBL, LOS, Operating Room time, and improved laboratory values postoperatively in open sagittal synostosis surgery. Addition of TXA further improved operative time and LOS....

Frontal sinus hypoplasia in unoperated older patients with craniosynostosis: a pilot study.

The purpose of this study is to determine whether patients with unoperated craniosynostosis have different frontal sinus pneumatization than unaffected controls.... Retrospective review was performed between 2009 and 2020 of previously unoperated patients with craniosynostosis older than 5 years old at first presentation to our institution. Total frontal sinus vo... Study group included nine patients, 5-39 years old, median age 7 years. Frontal sinus pneumatization was absent in 12% of the normal 7-year-old controls, while frontal sinus pneumatization was absent ... Frontal sinus pneumatization is suppressed in unreleased craniosynostosis and may be an intracranial space conservation phenomenon. This absent frontal sinus can have implications in future frontal re...

Surgical Timing and Neurocognitive Development among Patients with Craniosynostosis: Analysis of Confounders.

In 1988, Renier and Marchac asserted that children with craniosynostosis who undergo cranial vault remodeling (CVR) after 12 months of age experience delayed neurocognitive development compared to chi... Patients with nonsyndromic single-suture craniosynostosis who underwent CVR between 2009 and 2020 at Michigan Medicine were included ( n = 227). Sociodemographic and clinical variables were documented... The early and late groups contained 157 patients and 70 patients, respectively. Compared to the early group, the late group contained a larger proportion of patients who identified as non-White ( P = ... This study demonstrates that socioeconomic disadvantages and comorbid conditions are prevalent among patients who undergo delayed CVR and may represent a selection bias toward delayed neurocognitive d... Risk, II....

Utilization of carbonated calcium phosphate cement for contouring cranioplasty in patients with syndromic craniosynostosis.

Carbonated calcium phosphate (CCP) cement is an alloplastic material which has been increasingly utilized for cranioplasty reconstruction; however, there is a paucity of data investigating its use in ... Patients with syndromic craniosynostosis undergoing cranioplasty with CCP cement from 2009 to 2022 were retrospectively reviewed for prior medical and surgical history, cranioplasty size, cement usage... Twenty-one patients were included. Age at surgery was 16.2 ± 2.8 years, forehead cranioplasty area was 135 ± 112 cm... Our results suggest that aesthetic forehead ratings improve after CCP contouring cranioplasty and that the improvement is sustained in medium-term follow-up. Complications were uncommon, suggesting th...

Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study, 1997-2011.

Caffeine consumption is common during pregnancy, but published associations with birth defects are mixed. We updated estimates of associations between prepregnancy caffeine consumption and 48 specific... NBDPS was a large population-based case-control study conducted in 10 U.S. states. We categorized self-reported total dietary caffeine consumption (mg/day) from coffee, tea, soda, and chocolate as: <1... Our analysis included 30,285 case and 11,502 control children, with mothers of 52% and 54%, respectively, reporting consuming <100 mg caffeine, and 11% of mothers of both cases and controls reported c... Given the large number of estimates generated, some of the statistically significant results may be due to chance and thus the weakly increased aORs should be interpreted cautiously. This study suppor...